Sartorius Stedim Biotech S.A. (EPA:DIM)

France flag France · Delayed Price · Currency is EUR
177.90
-1.65 (-0.92%)
Jul 30, 2025, 5:35 PM CET
-0.92%
Market Cap17.31B
Revenue (ttm)2.90B
Net Income (ttm)225.20M
Shares Out97.30M
EPS (ttm)2.31
PE Ratio76.94
Forward PE36.35
Dividend0.69 (0.38%)
Ex-Dividend DateApr 2, 2025
Volume55,539
Average Volume77,845
Open179.70
Previous Close179.55
Day's Range177.90 - 181.90
52-Week Range148.75 - 239.80
Beta0.93
RSI34.24
Earnings DateJul 22, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog... [Read more]

Sector Healthcare
Founded 1978
Employees 9,901
Stock Exchange Euronext Paris
Ticker Symbol DIM
Full Company Profile

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.

Financial Statements

News

Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa

KIGALI, Rwanda and SAN FRANCISCO and AUBAGNE, France, July 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech, a...

1 day ago - GlobeNewsWire

Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible's Unique Cell-Based mRNA Design and Manufacturing Platform

AUBAGNE, France & BRATISLAVA, Slovakia--(BUSINESS WIRE)--Sartorius Stedim Biotech and Sensible Biotechnologies are scaling up a unique cell-based manufacturing platform for clinical-grade therapeutic ...

21 days ago - Business Wire

Sartorius Stedim Biotech SA (SDMHF) Q4 2024 Earnings Call Highlights: Navigating Growth Amid ...

Sartorius Stedim Biotech SA (SDMHF) Q4 2024 Earnings Call Highlights: Navigating Growth Amid Market Challenges

6 months ago - GuruFocus

Sartorius, Sartorius Stedim Biotech shares jump after results beat

Shares in Sartorius jumped 15.6% on Tuesday after the Franco-German lab supplies maker's preliminary annual results beat expectations and despite a cautious outlook for 2025.

6 months ago - Reuters

Sartorius Stedim Biotech S.A. (SDMHF) Q3 2024 Earnings Call Transcript

Sartorius Stedim Biotech S.A. (OTCPK:SDMHF) Q3 2024 Earnings Conference Call October 17, 2024 7:00 AM ET Company Participants Joachim Kreuzburg - Chairman René Fáber - Chief Executive Officer Florian ...

10 months ago - Seeking Alpha

Sartorius Stedim Biotech S.A. (SDMHF) H1 2024 Earnings Call Transcript

Sartorius Stedim Biotech S.A. (OTCPK:SDMHF) H1 2024 Earnings Conference Call July 18, 2024 1:45 AM ET Company Participants Dr. Joachim Kreuzburg - IR Rene Faber - Head of Bioprocess Solutions Division...

1 year ago - Seeking Alpha

Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript

Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

10 stocks for investors looking for ‘wonderful companies at a fair price'

As money managers talk about various methods of selecting quality companies, investors might also think about diversification, which can lower risk and broaden opportunities.

1 year ago - Market Watch

Sartorius Stedim Biotech S.A. (SDMHF) Q3 2023 Earnings Call Transcript

Sartorius Stedim Biotech S.A. (SDMHF) Q3 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

Sartorius Stedim Biotech S.A. (SDMHF) Q2 2023 Earnings Call Transcript

Sartorius Stedim Biotech S.A. (SDMHF) Q2 2023 Earnings Call Transcript

2 years ago - Seeking Alpha

Sartorius, Sartorius Stedim shares fall after Polyplus acquisition

Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA DIM, -6.51% fell in opening trade on Friday after the compan...

2 years ago - Market Watch

Sartorius Stedim Biotech S.A. (SDMHF) Q4 2022 Earnings Call Transcript

Sartorius Stedim Biotech S.A. (OTCPK:SDMHF) Q4 2022 Earnings Conference Call January 26, 2023 9:30 AM ET Company Participants Joachim Kreuzburg - CEO Rainer Lehmann - CFO, Member of Executive Board Co...

2 years ago - Seeking Alpha